Jump to Content Jump to Main Navigation

HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

Authors: Kajal Patel PhD¹, Soham Shukla PharmD¹, Jennifer Hanlon MPH², Kelly Bell PharmD¹, Laurie Eliason MPH², and Cosmina Hogea PhD³

View More View Less

¹ GlaxoSmithKine, Collegeville, PA
| ² GlaxoSmithKline, Waltham, MA
| ³ GlaxoSmithKline, Philadelphia, PA

Volume/Issue:: Volume 19: Issue 3.5

Online Publication Date:: 17 Mar 2021

DOI:: https://doi.org/10.6004/jnccn.2020.7726

Restricted access

All currencies in US Dollar

Corresponding Author: Kajal Patel, PhD

Print
Save
Cite
Email this content

Share Link

Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:

https://jnccn.org/abstract/journals/jnccn/19/3.5/article-pHSR21-067.xml
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully

Top

Copyright:: Copyright © 2021 by the National Comprehensive Cancer Network 2021

Article Category:: Abstract

Print Publication Date:: 20 Mar 2021

Online Publication Date:: 17 Mar 2021

Get Permissions

Similar articles in Google Scholar

	All Time	Past Year	Past 30 Days
Abstract Views	0	0	0
Full Text Views	94	94	10
PDF Downloads	135	135	5
EPUB Downloads	0	0	0